Med-IQ Logo
Get CME/CE
Journal Supplement Journal Supplement

Diagnosing and Managing Parkinson’s Disease: Practical Strategies for the Federal Healthcare Professional


Time to complete:
60 Minutes
Released:
4/26/11
Expires:
4/25/12

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)

Journal SupplementJournal Supplement
Time to complete:
60 Minutes

Released:
4/26/11

Expires:
4/25/12

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)
Share on:
Journal SupplementJournal Supplement

Share on:


Time to complete:
60 Minutes
Released:
4/26/11
Expires:
4/25/12


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)


Overview: Each year, the United States Department of Veterans Affairs (VA) treats an estimated 40,000 Veterans with Parkinson’s disease (PD). This number, as well as the burden imposed on the VA system, is expected to increase substantially due to the recent ruling that added PD to the list of presumed service-related disorders for Veterans who served in combat roles in Vietnam. This policy shift is based on evidence suggesting that Agent Orange exposure may increase the risk of PD. Because patients present at different stages of the disease and with varying levels of symptom severity, PD treatment must be highly individualized and requires consideration of multiple patient-specific factors. This educational activity is designed to help clinicians in the federal healthcare system become more confident and competent in the recognition, diagnosis, and optimal management of this complex disease.

Authors

John Duda, MD
Director
Parkinson's Disease Research, Education and Clinical Center
Assistant Professor of Neurology
University of Pennsylvania School of Medicine
Philadelphia, PA

Richard Robinson
Sherborn, MA


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

John Duda, MD, has indicated no real or apparent conflicts and has received no compensation for participating in the development of this activity.

The writer (Richard Robinson), activity planners (Allison Gardner and Rebecca L. Julian), and other employees of Med-IQ have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Teva Neuroscience.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.